EX-12.1 5 ex-12d1.htm EX-12.1 mrns_currentfolio_ex12_1

Exhibit 12.1

 

Marinus Pharmaceuticals, Inc.

Computation of Ratio of Earnings (Loss) to Combined Fixed Charges and Preferred Stock Dividends

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended

 

Years ended

 

 

September 30,

 

December 31,

(Dollars in thousands)

    

2017

    

2016

    

2015

    

2014

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) available for fixed charges:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$
(14,160)

 

$
(28,643)

 

$
(24,850)

 

$
(10,833)

Add: Fixed charges, as calculated below

 

 
177

 

 
487

 

 
484

 

 
121

Total earnings (loss) available for fixed charges

 

$
(13,983)

 

$
(28,156)

 

$
(24,366)

 

$
(10,712)

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed charges:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense (a)

 

$
159

 

$
464

 

$
475

 

$
117

Estimated interest expense portion of rental expense (b)

 

 
18

 

 
23

 

 
9

 

 
4

Total fixed charges

 

$
177

 

$
487

 

$
484

 

$
121

 

 

 

 

 

 

 

 

 

 

 

 

 

Deficiency of earnings available to cover fixed charges

 

$
(14,160)

 

$
(28,643)

 

$
(24,850)

 

$
(10,833)

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend requirements

 

$

—

 

$

—

 

$

—

 

$
(2,545)

 

 

 

 

 

 

 

 

 

 

 

 

 

Deficiency of earnings available to cover fixed charges and preferred stock dividend requirements

 

$
(14,160)

 

$
(28,643)

 

$
(24,850)

 

$
(13,378)

(a)

Interest expense includes amortization of debt issuance costs

(b)

Interest expense portion of rental expense is estimated using the company's cost of borrowing applied to all rental expense